BE674919A - - Google Patents
Info
- Publication number
- BE674919A BE674919A BE674919DA BE674919A BE 674919 A BE674919 A BE 674919A BE 674919D A BE674919D A BE 674919DA BE 674919 A BE674919 A BE 674919A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH41465A CH458365A (de) | 1965-01-12 | 1965-01-12 | Verfahren zur Herstellung von neuen Picolylamin-Derivaten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE674919A true BE674919A (US06342305-20020129-C00040.png) | 1966-07-11 |
Family
ID=4186481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE674919D BE674919A (US06342305-20020129-C00040.png) | 1965-01-12 | 1966-01-10 |
Country Status (11)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4406903A (en) * | 1981-01-21 | 1983-09-27 | John Wyeth And Brother Limited | Xanthine derivatives useful as antidepressives |
| ES2362998T3 (es) | 2002-08-19 | 2011-07-18 | Pfizer Inc. | Terapia de combinación para enfermedades hiperproliferativas. |
| US20060063803A1 (en) * | 2004-09-23 | 2006-03-23 | Pfizer Inc | 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| EP2094643B1 (en) | 2006-12-01 | 2012-02-29 | Bristol-Myers Squibb Company | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
| EP2986599A1 (en) | 2013-04-17 | 2016-02-24 | Pfizer Inc. | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| EP3911648A4 (en) | 2019-01-18 | 2022-10-26 | Astrazeneca AB | PCSK9 INHIBITORS AND METHODS OF USE THEREOF |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3032554A (en) * | 1962-05-01 | Process for the preparation of new | ||
| US3029239A (en) * | 1954-04-17 | 1962-04-10 | Chemiewerk Homburg Zweignieder | Basic substituted 1-and 7-alkylxanthines or salts thereof |
| DE1011424B (de) * | 1954-04-17 | 1957-07-04 | Chemiewerk Homburg Ag | Verfahren zur Herstellung von basisch substituierten 7-Alkyl-xanthinderivaten oder deren Salzen |
| DE1018869B (de) * | 1954-12-14 | 1957-11-07 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung von Aminoalkylpurinderivaten |
| DE1112983B (de) * | 1958-11-21 | 1961-08-24 | Sandoz Ag | Verfahren zur Herstellung von Theophyllin-Derivaten |
| CH402872A (de) * | 1959-12-18 | 1965-11-30 | Nippon Shinyaku Co Ltd | Verfahren zur Herstellung von Theophyllin- oder Theobromin-Derivaten |
-
0
- NL NL128191D patent/NL128191C/xx active
- GB GB1084150D patent/GB1084150A/en active Active
-
1965
- 1965-01-12 CH CH41465A patent/CH458365A/de unknown
- 1965-01-21 FR FR45538A patent/FR1463438A/fr not_active Expired
- 1965-10-14 DE DE19651545772 patent/DE1545772B1/de not_active Withdrawn
- 1965-10-20 US US499047A patent/US3350400A/en not_active Expired - Lifetime
-
1966
- 1966-01-07 ES ES0321531A patent/ES321531A1/es not_active Expired
- 1966-01-10 NL NL6600250A patent/NL6600250A/xx unknown
- 1966-01-10 BE BE674919D patent/BE674919A/xx unknown
- 1966-01-11 BR BR176358/66A patent/BR6676358D0/pt unknown
- 1966-01-11 DK DK12166AA patent/DK114482B/da unknown
- 1966-01-11 FR FR45417A patent/FR5128M/fr not_active Expired
-
1978
- 1978-12-06 IT IT7830644A patent/IT7830644A0/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CH458365A (de) | 1968-08-30 |
| US3350400A (en) | 1967-10-31 |
| ES321531A1 (es) | 1966-11-01 |
| NL128191C (US06342305-20020129-C00040.png) | |
| FR1463438A (fr) | 1966-12-23 |
| DK114482B (da) | 1969-07-07 |
| GB1084150A (US06342305-20020129-C00040.png) | |
| FR5128M (US06342305-20020129-C00040.png) | 1967-06-05 |
| BR6676358D0 (pt) | 1973-09-06 |
| NL6600250A (US06342305-20020129-C00040.png) | 1966-07-13 |
| DE1545772B1 (de) | 1969-12-11 |
| IT7830644A0 (it) | 1978-12-06 |
